PMID: 11914172Mar 27, 2002Paper

Pharmacogenetics of bipolar disorder

Current Psychiatry Reports
Hader A MansourVishwajit L Nimgaonkar

Abstract

To review the pharmacogenetics of bipolar disorders, the authors searched databases for genetic association and linkage studies involving response to long-term prophylactic lithium treatment, as well as treatment with antidepressants or clozapine. Significant ethnic variations in the metabolism and efficacy of antidepressants, as well as clozapine, have been reported by several groups. Systematic studies suggest that that genetic factors affect the response to prophylactic lithium treatment. Numerous associations between the three traits of interest and candidate gene polymorphisms have been proposed. Among these, an association between the serotonin transporter gene and response to serotonin reuptake inhibitors appears robust. Considerable interest has also focused on serotonergic gene polymorphisms and response to clozapine. Response to pharmacotherapy in bipolar disorders may be mediated by genetic factors, but the role played by heritability is unknown.

References

Feb 1, 1978·Archives of General Psychiatry·J Youngerman, I A Canino
Jan 1, 1975·Modern Problems of Pharmacopsychiatry·J Mendlewicz, F Stallone
Jul 9, 1992·Nature·H H Van TolV Jovanovic
Mar 1, 1991·Trends in Pharmacological Sciences·W Kalow
Jan 1, 1990·Progress in Liver Diseases·U A MeyerM Blum
Oct 1, 1990·Archives of General Psychiatry·J A LiebermanE J Yunis
Apr 1, 1986·The American Journal of Psychiatry·J J SramekG M Simpson
Oct 1, 1988·Clinical Pharmacology and Therapeutics·E SteinerF Sjöqvist
Aug 1, 1986·Journal of Clinical Psychopharmacology·M GaviriaJ I Javaid
Sep 1, 1973·The American Journal of Psychiatry·J MendlewiczF Stallone
Sep 1, 1981·The American Journal of Psychiatry·R L Binder, R Levy
Apr 1, 1983·The American Journal of Psychiatry·K M Lin, E Finder
Apr 1, 1984·British Journal of Clinical Pharmacology·M V RudorferW Z Potter
Apr 1, 1981·Psychiatry Research·D H McKnewE S Gershon
Oct 1, 1982·American Journal of Psychotherapy·L R Marcos, R Cancro
Jan 4, 1996·The New England Journal of Medicine·J M Kane
Oct 1, 1994·Journal of Affective Disorders·P GrofM Walsh
Oct 1, 1994·Acta Psychiatrica Scandinavica·M AldaM Walsh
Nov 1, 1994·British Journal of Clinical Pharmacology·L BertilssonJ Benitez
Jun 21, 1994·Proceedings of the National Academy of Sciences of the United States of America·W H BerrettiniE S Gershon
Mar 1, 1993·Clinical Pharmacokinetics·J van Harten
Jun 1, 1996·Journal of Neurochemistry·A HeilsK P Lesch
Jun 1, 1996·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·D D Miller
Aug 1, 1996·Therapeutic Drug Monitoring·K Brøsen
Dec 1, 1996·The Annals of Pharmacotherapy·L J Cohen, C L De Vane
Mar 26, 1998·American Journal of Medical Genetics·L E EsterlingS D Detera-Wadleigh
Aug 5, 1998·Journal of Clinical Psychopharmacology·J A CarrilloJ Benítez
Oct 28, 1998·Journal of Psychiatric Research·L FranchiniE Smeraldi
Nov 18, 1998·Archives of General Psychiatry·S Bender, C B Eap
Jan 8, 1999·Acta Psychiatrica Scandinavica·A SerrettiE Smeraldi

❮ Previous
Next ❯

Citations

May 17, 2014·AJNR. American Journal of Neuroradiology·T-S LeeK R R Krishnan
Apr 14, 2004·The Pharmacogenomics Journal·F MamdaniG Turecki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here